Your session is about to expire
← Back to Search
Denosumab (Cohort A) for Giant Cell Tumor
Study Summary
This trial will follow subjects who were treated in a previous trial for an additional 5 years to assess long-term safety.
- Giant Cell Tumor
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
To which ailments is Denosumab (Cohort A) typically prescribed?
"Patients with bone-related conditions such as skeletally mature and those exhibiting hormonal imbalances due to androgens can receive treatment from Denosumab (Cohort A)."
What is the maximum number of participants allowed in this research study?
"This clinical trial is no longer searching for participants. It was originally posted in November 2017, with the last update being made in December 2021. If you are looking to join another study, there are presently 54 trials actively seeking patients with giant cell tumors of bone and 47 recruiting for Denosumab (Cohort A)."
How many medical establishments are conducting this study?
"Currently, 10 medical sites are enrolling patients. Apart from Minneapolis, Philadelphia and Santa Monica, other locales include... It is advised to choose a trial center close to you so as to lessen commute requirements should you opt-in for the study."
What other investigations have been performed on the efficacy of Denosumab (Cohort A)?
"Research on denosumab (Cohort A) was conducted at Xavier Nogues in 2016 with 110 studies completed. At present, there are 47 open clinical trials recruiting patients, primarily based out of Minneapolis, Minnesota."
Has the FDA rendered a verdict on Denosumab (Cohort A) yet?
"The safety of Denosumab (Cohort A) has been established and is given a rating of 3 on the 1-3 scale used by Power, as it is currently approved for use in Phase 4 clinical trials."
Is this research study open to new participants?
"This clinical trial is no longer accepting applicants, as reflected on the clinicaltrials.gov website; it was first posted in November 2017 and last updated in December 2021. Nevertheless, there are presently 101 separate studies that remain open to participants."
Share this study with friends
Copy Link
Messenger